{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:20:08Z","timestamp":1772173208317,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010563","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000}}],"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1745302"],"award-info":[{"award-number":["1745302"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1-R61-AI161805-01"],"award-info":[{"award-number":["1-R61-AI161805-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute of MGH, MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The rise of SARS-CoV-2 variants and the history of outbreaks caused by zoonotic coronaviruses point to the need for next-generation vaccines that confer protection against variant strains. Here, we combined analyses of diverse sequences and structures of coronavirus spikes with data from deep mutational scanning to design SARS-CoV-2 variant antigens containing the most significant mutations that may emerge. We trained a neural network to predict RBD expression and ACE2 binding from sequence, which allowed us to determine that these antigens are stable and bind to ACE2. Thus, they represent viable variants. We then used a computational model of affinity maturation (AM) to study the antibody response to immunization with different combinations of the designed antigens. The results suggest that immunization with a cocktail of the antigens is likely to promote evolution of higher titers of antibodies that target SARS-CoV-2 variants than immunization or infection with the wildtype virus alone. Finally, our analysis of 12 coronaviruses from different genera identified the S2\u2019 cleavage site and fusion peptide as potential pan-coronavirus vaccine targets.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1010563","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:48:46Z","timestamp":1664200126000},"page":"e1010563","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-0597","authenticated-orcid":true,"given":"Eric","family":"Wang","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1268-9602","authenticated-orcid":true,"given":"Arup K.","family":"Chakraborty","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"issue":"23","key":"pcbi.1010563.ref001","first-page":"e01313","article-title":"Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants","volume":"95","author":"A Choi","journal-title":"Journal of Virology"},{"issue":"1","key":"pcbi.1010563.ref002","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-021-25479-6","article-title":"Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum","volume":"12","author":"TA Bates","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1010563.ref003","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41467-022-28089-y","article-title":"Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant","volume":"13","author":"B Li","year":"2022","journal-title":"Nature Communications"},{"issue":"16","key":"pcbi.1010563.ref004","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1016\/j.cell.2021.06.020","article-title":"Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum","volume":"184","author":"C Liu","year":"2021","journal-title":"Cell"},{"issue":"7","key":"pcbi.1010563.ref005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMc2107799","article-title":"Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.","volume":"385","author":"V-V Edara","year":"2021","journal-title":"New England Journal of Medicine."},{"issue":"7871","key":"pcbi.1010563.ref006","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"D Planas","year":"2021","journal-title":"Nature"},{"issue":"2","key":"pcbi.1010563.ref007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.","volume":"385","author":"LJ Abu-Raddad","year":"2021","journal-title":"New England Journal of Medicine."},{"issue":"6","key":"pcbi.1010563.ref008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma Neutralization of the SARS-CoV-2 Omicron Variant.","volume":"386","author":"F Schmidt","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"7898","key":"pcbi.1010563.ref009","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"D Planas","year":"2022","journal-title":"Nature"},{"issue":"7821","key":"pcbi.1010563.ref010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals.","volume":"584","author":"DF Robbiani","year":"2020","journal-title":"Nature"},{"issue":"6506","key":"pcbi.1010563.ref011","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.","volume":"369","author":"F Rogers Thomas","year":"2020","journal-title":"Science"},{"issue":"7821","key":"pcbi.1010563.ref012","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"SJ Zost","year":"2020","journal-title":"Nature"},{"key":"pcbi.1010563.ref013","doi-asserted-by":"crossref","first-page":"e61390","DOI":"10.7554\/eLife.61390","article-title":"ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.","volume":"9","author":"N Zamorano Cuervo","year":"2020","journal-title":"eLife."},{"issue":"1","key":"pcbi.1010563.ref014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal Centers.","volume":"30","author":"GD Victora","year":"2012","journal-title":"Annual Review of Immunology"},{"key":"pcbi.1010563.ref015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.","volume":"10","author":"EA van Erp","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"pcbi.1010563.ref016","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0167-5699(93)90145-B","article-title":"Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation","volume":"14","author":"TB Kepler","year":"1993","journal-title":"Immunology Today"},{"issue":"1\u20133","key":"pcbi.1010563.ref017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(97)87000-9","article-title":"Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts","volume":"56","author":"M Oprea","year":"1997","journal-title":"Immunology Letters"},{"issue":"5","key":"pcbi.1010563.ref018","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.immuni.2007.05.002","article-title":"Germinal-Center B Cells in the Zone","volume":"26","author":"R. Brink","year":"2007","journal-title":"Immunity"},{"issue":"1","key":"pcbi.1010563.ref019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11538-012-9799-9","article-title":"A model for migratory B cell oscillations from receptor down-regulation induced by external chemokine fields","volume":"75","author":"C Chan","year":"2013","journal-title":"Bull Math Biol"},{"issue":"1","key":"pcbi.1010563.ref020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.celrep.2012.05.010","article-title":"A Theory of Germinal Center B Cell Selection, Division, and Exit.","volume":"2","author":"M Meyer-Hermann","year":"2012","journal-title":"Cell Reports."},{"issue":"6","key":"pcbi.1010563.ref021","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/eji.1830260626","article-title":"Affinity maturation and hypermutation in a simulation of the humoral immune response","volume":"26","author":"F Celada","year":"1996","journal-title":"European Journal of Immunology"},{"issue":"4","key":"pcbi.1010563.ref022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2015.01.027","article-title":"Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies","volume":"160","author":"S Wang","year":"2015","journal-title":"Cell"},{"issue":"33","key":"pcbi.1010563.ref023","doi-asserted-by":"crossref","first-page":"20077","DOI":"10.1073\/pnas.1919329117","article-title":"Optimizing immunization protocols to elicit broadly neutralizing antibodies","volume":"117","author":"G Sprenger Kayla","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"45","key":"pcbi.1010563.ref024","doi-asserted-by":"crossref","first-page":"E7039","DOI":"10.1073\/pnas.1614940113","article-title":"Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens","volume":"113","author":"JS Shaffer","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"pcbi.1010563.ref025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cels.2020.09.005","article-title":"Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.","volume":"11","author":"A Amitai","year":"2020","journal-title":"Cell Systems"},{"issue":"5","key":"pcbi.1010563.ref026","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.4049\/jimmunol.1401054","article-title":"Simulation of B Cell Affinity Maturation Explains Enhanced Antibody Cross-Reactivity Induced by the Polyvalent Malaria Vaccine AMA1","volume":"193","author":"S Chaudhury","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"1676","key":"pcbi.1010563.ref027","doi-asserted-by":"crossref","first-page":"20140245","DOI":"10.1098\/rstb.2014.0245","article-title":"Trade-offs in antibody repertoires to complex antigens. Philosophical Transactions of the Royal Society B","volume":"370","author":"LM Childs","year":"2015","journal-title":"Biological Sciences"},{"issue":"37","key":"pcbi.1010563.ref028","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1073\/pnas.1505207112","article-title":"Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising","volume":"112","author":"S Luo","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"pcbi.1010563.ref029","doi-asserted-by":"crossref","first-page":"052408","DOI":"10.1103\/PhysRevE.103.052408","article-title":"Mechanisms underlying vaccination protocols that may optimally elicit broadly neutralizing antibodies against highly mutable pathogens","volume":"103","author":"RS Ganti","year":"2021","journal-title":"Physical Review E"},{"issue":"23","key":"pcbi.1010563.ref030","doi-asserted-by":"crossref","first-page":"12693","DOI":"10.1073\/pnas.1914586117","article-title":"Tuning environmental timescales to evolve and maintain generalists","volume":"117","author":"V Sachdeva","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"22","key":"pcbi.1010563.ref031","first-page":"e00983","article-title":"How Germinal Centers Evolve Broadly Neutralizing Antibodies: the Breadth of the Follicular Helper T Cell Response","volume":"91","author":"J De Boer Rob","journal-title":"Journal of Virology"},{"key":"pcbi.1010563.ref032","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"L van Dorp","year":"2020","journal-title":"Infection, Genetics and Evolution"},{"issue":"1","key":"pcbi.1010563.ref033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2148-4-21","article-title":"Moderate mutation rate in the SARS coronavirus genome and its implications","volume":"4","author":"Z Zhao","year":"2004","journal-title":"BMC Evolutionary Biology"},{"issue":"13","key":"pcbi.1010563.ref034","doi-asserted-by":"crossref","first-page":"109760","DOI":"10.1016\/j.celrep.2021.109760","article-title":"Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies","volume":"36","author":"CA Jette","year":"2021","journal-title":"Cell Reports"},{"issue":"1","key":"pcbi.1010563.ref035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2105-12-226","article-title":"StralSV: assessment of sequence variability within similar 3D structures and application to polio RNA-dependent RNA polymerase","volume":"12","author":"AT Zemla","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"pcbi.1010563.ref036","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"R Nachbagauer","year":"2021","journal-title":"Nature Medicine"},{"issue":"3","key":"pcbi.1010563.ref037","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies","volume":"45","author":"M Steichen Jon","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"pcbi.1010563.ref038","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","article-title":"Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.","volume":"50","author":"MG Pauthner","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"pcbi.1010563.ref039","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","article-title":"Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice","volume":"166","author":"A Escolano","year":"2016","journal-title":"Cell"},{"issue":"1","key":"pcbi.1010563.ref040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12075","article-title":"HIV-1 neutralizing antibodies: understanding nature\u2019s pathways","volume":"254","author":"JR Mascola","year":"2013","journal-title":"Immunological Reviews"},{"issue":"1","key":"pcbi.1010563.ref041","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41467-020-19650-8","article-title":"Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells","volume":"11","author":"D Huang","year":"2020","journal-title":"Nature Communications"},{"issue":"5","key":"pcbi.1010563.ref042","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.","volume":"182","author":"TN Starr","year":"2020","journal-title":"Cell."},{"issue":"1","key":"pcbi.1010563.ref043","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.","volume":"29","author":"AJ Greaney","year":"2021","journal-title":"Cell Host & Microbe."},{"issue":"1","key":"pcbi.1010563.ref044","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/s41467-021-24435-8","article-title":"Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies","volume":"12","author":"AJ Greaney","year":"2021","journal-title":"Nature Communications"},{"issue":"4","key":"pcbi.1010563.ref045","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","article-title":"Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016","volume":"2","author":"TN Starr","year":"2021","journal-title":"Cell Reports Medicine"},{"issue":"7874","key":"pcbi.1010563.ref046","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"TN Starr","year":"2021","journal-title":"Nature"},{"issue":"10","key":"pcbi.1010563.ref047","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","article-title":"Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail","volume":"6","author":"J Dong","year":"2021","journal-title":"Nature Microbiology"},{"issue":"3","key":"pcbi.1010563.ref048","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python.","volume":"17","author":"P Virtanen","year":"2020","journal-title":"Nature Methods"},{"key":"pcbi.1010563.ref049","volume-title":"Deep learning with Keras: implement neural networks with Keras on Theano and TensorFlow.","author":"A Gull\u00ec","year":"2017"},{"key":"pcbi.1010563.ref050","author":"M Abadi","year":"2015","journal-title":"TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems."},{"issue":"7839","key":"pcbi.1010563.ref051","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"CO Barnes","year":"2020","journal-title":"Nature"},{"issue":"12","key":"pcbi.1010563.ref052","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.cell.2021.04.032","article-title":"B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.","volume":"184","author":"JF Scheid","year":"2021","journal-title":"Cell."},{"issue":"5","key":"pcbi.1010563.ref053","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chom.2021.04.005","article-title":"A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection","volume":"29","author":"H Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"pcbi.1010563.ref054","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/11560500_15","volume-title":"Computational Life Sciences","author":"E Krissinel","year":"2005"},{"issue":"3","key":"pcbi.1010563.ref055","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of Macromolecular Assemblies from Crystalline State","volume":"372","author":"E Krissinel","year":"2007","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"pcbi.1010563.ref056","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcc.21303","article-title":"Crystal contacts as nature\u2019s docking solutions","volume":"31","author":"E. Krissinel","year":"2010","journal-title":"Journal of Computational Chemistry"},{"issue":"1","key":"pcbi.1010563.ref057","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1038\/s41598-018-25960-1","article-title":"Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies.","volume":"8","author":"T Mohan","year":"2018","journal-title":"Scientific Reports"},{"key":"pcbi.1010563.ref058","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.1987.tb00507.x","article-title":"Mutation drift and repertoire shift in the maturation of the immune response.","volume":"96","author":"C Berek","year":"1987","journal-title":"Immunol Rev"},{"issue":"suppl_1","key":"pcbi.1010563.ref059","doi-asserted-by":"crossref","first-page":"D195","DOI":"10.1093\/nar\/gkj017","article-title":"PINT: Protein\u2013protein Interactions Thermodynamic Database","volume":"34","author":"MDS Kumar","year":"2006","journal-title":"Nucleic Acids Research"},{"issue":"6277","key":"pcbi.1010563.ref060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.aad3439","article-title":"Visualizing antibody affinity maturation in germinal centers","volume":"351","author":"MJ Tas Jeroen","year":"2016","journal-title":"Science"},{"issue":"4","key":"pcbi.1010563.ref061","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chom.2021.03.009","article-title":"Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.","volume":"29","author":"VV Edara","year":"2021","journal-title":"Cell Host & Microbe."},{"issue":"9","key":"pcbi.1010563.ref062","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","author":"D Zhou","year":"2021","journal-title":"Cell"},{"issue":"7857","key":"pcbi.1010563.ref063","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"P Wang","year":"2021","journal-title":"Nature"},{"issue":"7855","key":"pcbi.1010563.ref064","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Z Wang","year":"2021","journal-title":"Nature"},{"issue":"7867","key":"pcbi.1010563.ref065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Z Wang","year":"2021","journal-title":"Nature"},{"issue":"1","key":"pcbi.1010563.ref066","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","article-title":"Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting","volume":"180","author":"L Mesin","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pcbi.1010563.ref067","doi-asserted-by":"crossref","first-page":"16944","DOI":"10.1038\/s41598-020-74101-0","article-title":"The sequence at Spike S1\/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.","volume":"10","author":"M \u00d6rd","year":"2020","journal-title":"Scientific Reports."},{"issue":"2","key":"pcbi.1010563.ref068","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.","volume":"181","author":"M Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pcbi.1010563.ref069","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"M-M Zhao","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"pcbi.1010563.ref070","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","article-title":"SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography","volume":"11","author":"S Klein","year":"2020","journal-title":"Nature Communications"},{"issue":"12","key":"pcbi.1010563.ref071","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1214913110","article-title":"Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies","volume":"110","author":"K Harris Audray","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6558","key":"pcbi.1010563.ref072","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1126\/science.abi4506","article-title":"Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice","volume":"373","author":"R Martinez David","year":"2021","journal-title":"Science"},{"issue":"11","key":"pcbi.1010563.ref073","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.2001438","article-title":"Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines","volume":"206","author":"S Prakash","year":"2021","journal-title":"The Journal of Immunology"},{"issue":"4","key":"pcbi.1010563.ref074","doi-asserted-by":"crossref","DOI":"10.3390\/v12040360","article-title":"Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.","volume":"12","author":"S Srinivasan","year":"2020","journal-title":"Viruses"},{"issue":"11","key":"pcbi.1010563.ref075","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/prot.25967","article-title":"Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition.","volume":"88","author":"L. Guruprasad","year":"2020","journal-title":"Proteins: Structure, Function, and Bioinformatics."},{"issue":"17","key":"pcbi.1010563.ref076","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1128\/JVI.00560-06","article-title":"Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors","volume":"80","author":"H Hofmann","year":"2006","journal-title":"Journal of Virology"},{"issue":"6522","key":"pcbi.1010563.ref077","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"W Ng Kevin","year":"2020","journal-title":"Science"},{"issue":"6559","key":"pcbi.1010563.ref078","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"D Pinto","year":"2021","journal-title":"Science"},{"issue":"6","key":"pcbi.1010563.ref079","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"MM Sauer","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"pcbi.1010563.ref080","first-page":"eabi9215","article-title":"A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection","author":"P Zhou","journal-title":"Science Translational Medicine"},{"issue":"7855","key":"pcbi.1010563.ref081","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"S Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"issue":"9","key":"pcbi.1010563.ref082","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"HM Yassine","year":"2015","journal-title":"Nature Medicine"},{"issue":"31","key":"pcbi.1010563.ref083","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"G Bommakanti","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"pcbi.1010563.ref084","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies","volume":"87","author":"F Krammer","year":"2013","journal-title":"Journal of Virology"},{"issue":"12","key":"pcbi.1010563.ref085","doi-asserted-by":"crossref","first-page":"110143","DOI":"10.1016\/j.celrep.2021.110143","article-title":"SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity","volume":"37","author":"MG Joyce","year":"2021","journal-title":"Cell Reports"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010563","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:54:30Z","timestamp":1665064470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010563"}},"subtitle":[],"editor":[{"given":"Anders","family":"Wallqvist","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010563","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.24.477469","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]}}}